首页> 外文期刊>APMIS: Acta Pathologica, Microbiologica et Immunologica Scandinavica >Inducible nitric oxide synthase expression and its prognostic significance in colorectal cancer.
【24h】

Inducible nitric oxide synthase expression and its prognostic significance in colorectal cancer.

机译:诱导型一氧化氮合酶的表达及其在大肠癌中的预后意义。

获取原文
获取原文并翻译 | 示例
           

摘要

Nitric oxide synthases (NOS) are expressed in colorectal cancer. The aim of this study was to examine the inducible NOS (iNOS) expression in colorectal cancer and to investigate its prognostic relevance. Tissue sections of primary tumors from 132 patients undergoing curative resection for colorectal cancer were immunohistochemically examined for iNOS expression. The expression pattern of iNOS was correlated with various clinicopathological characteristics and survival. iNOS immunoreactivity was observed in the cytoplasm of tumor epithelial cells in 60 patients (45.5%) and positively correlated with lymph node involvement (p = 0.019). No significant correlation was found between iNOS expression and various clinicopathological characteristics, including age, gender, tumor location, tumor size, tumor grade, T stage, and Union International Contra la Cancrum (UICC) stage. Survival analysis showed a significant correlation between iNOS-positive tumors and poor disease-specific survival (p < 0.0001), with independent prognostic significance in multivariate analysis (HR = 4.42; p < 0.0001). Patients with stage II disease and iNOS-positive tumors had significantly worse disease-specific survival than those with iNOS-negative tumors (p < 0.0001). In addition, patients with stage III disease and iNOS-positive tumors had significantly worse disease-specific survival than those with iNOS-negative tumors (p = 0.001). The ability of iNOS to predict outcome in colorectal cancer patients may be independent of other known prognostic factors, providing a new molecular marker with significant potential for clinical utility.
机译:一氧化氮合酶(NOS)在大肠癌中表达。这项研究的目的是检查大肠癌中诱导型NOS(iNOS)的表达并探讨其预后的相关性。免疫组化检查了132例接受结直肠癌根治性切除术的原发肿瘤的组织切片中iNOS的表达。 iNOS的表达模式与各种临床病理特征和生存率相关。在60例患者(45.5%)的肿瘤上皮细胞胞浆中观察到iNOS免疫反应,并且与淋巴结受累呈正相关(p = 0.019)。在iNOS表达与各种临床病理特征之间没有发现显着相关性,包括年龄,性别,肿瘤位置,肿瘤大小,肿瘤等级,T期和联合国际对照坎昆(UICC)期。生存分析显示iNOS阳性肿瘤与不良疾病特异性生存之间存在显着相关性(p <0.0001),在多变量分析中具有独立的预后意义(HR = 4.42; p <0.0001)。 II期疾病和iNOS阳性肿瘤的患者的疾病特异性生存率显着低于iNOS阴性肿瘤的患者(p <0.0001)。此外,III期疾病和iNOS阳性肿瘤患者的疾病特异性生存率显着低于iNOS阴性肿瘤(p = 0.001)。 iNOS预测结直肠癌患者预后的能力可能独立于其他已知的预后因素,为临床应用提供了具有重大潜力的新分子标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号